Role of NADPH-cytochrome P450 reductase and cytochrome-b5/NADH-b5 reductase in variability of CYP3A activity in human liver microsomes.
Role of NADPH-cytochrome P450 reductase and cytochrome-b5/NADH-b5 reductase in variability of CYP3A activity in human liver microsomes.
复制标题
DOI：
10.1124/dmd.108.023424
复制
发表时间：
2009-01
影响因子：
3.9
通讯作者：
Court, Michael H.
中科院分区：
文献类型：
--
作者：
Gan, Lu;von Moltke, Lisa L.;Trepanier, Lauren A.;Harmatz, Jerold S.;Greenblatt, David J.;Court, Michael H.
NADPH-cytochrome P450 reductase (CPR) and cytochrome b5 (b5) together with NADH b5 reductase (b5R) play important roles in cytochrome P450 (CYP) 3A-mediated drug metabolism via electron transfer. However, it is not clear whether variability in expression of these accessory proteins contribute to the known interindividual variability in CYP3A activity. CPR and b5 were measured in human liver microsomes (HLMs) by spectrophotometry and immunoblotting. HLMs from elderly (≥46 years) male donors (n = 11) averaged 27% (P = 0.034) and 41% (P = 0.011) lower CPR levels than young (≤45 years) male donors (n = 21) for spectrophotometric and immunoblot values, respectively. Similarly, HLMs from elderly male donors averaged 43% (P = 0.034) and 47% (P = 0.011) lower b5 levels than young male donors for spectrophotometric and immunoblot values, respectively. α-Lipoic acid and 6-propyl-2-thiouracil (PTU) were evaluated for selectivity of inhibition of CPR and b5R activities (respectively) using recombinant enzymes and HLMs, as well as for effects on CYP3A-mediated triazolam hydroxylation in HLMs with either NADH or β-NADPH. The results indicate that both compounds are relatively nonselective inhibitors of CPR and b5R activities. Finally, we used multivariate regression analysis and showed that variability in CPR or b5 expression between HLMs does not contribute significantly to variability in CYP3A-mediated midazolam hydroxylation. Consequently, while aging is associated with decreased CPR and b5 expression in human livers, this effect does not contribute to CYP3A variability.
登录
查看更多内容
影响因子：
3.9
作者：
Guengerich, FP
通讯作者：
Guengerich, FP
影响因子：
5.3
作者：
SCHMUCKER, DL;WANG, RK
通讯作者：
WANG, RK
影响因子：
3.9
作者：
Voice, MW;Zhang, Y;Friedberg, T
通讯作者：
Friedberg, T
DOI：
10.1124/jpet.103.059311
发表时间：
2004-03-01
影响因子：
3.5
作者：
Patki, KC;von Moltke, LL;Greenblatt, DJ
通讯作者：
Greenblatt, DJ
影响因子：
2.9
作者：
PORTER, TD;KASPER, CB
通讯作者：
KASPER, CB